company background image
OPNT logo

Opiant Pharmaceuticals NasdaqCM:OPNT Rapporto sulle azioni

Ultimo prezzo

US$20.65

Cap. di mercato

US$108.8m

7D

-1.3%

1Y

-22.3%

Aggiornato

03 Mar, 2023

Dati

Dati finanziari dell'azienda +

Opiant Pharmaceuticals, Inc.

NasdaqCM:OPNT Rapporto sulle azioni

Cap. di mercato: US$108.8m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

OPNT Panoramica delle azioni

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

OPNT analisi fondamentale
Punteggio fiocco di neve
Valutazione3/6
Crescita futura5/6
Prestazioni passate0/6
Salute finanziaria5/6
Dividendi0/6

Opiant Pharmaceuticals, Inc. Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Opiant Pharmaceuticals
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$20.65
Massimo di 52 settimaneUS$28.15
Minimo di 52 settimaneUS$7.34
Beta0.83
1Variazione di 1 mese3.10%
Variazione a 3 mesi2.38%
Variazione di 1 anno-22.31%
3Variazione a 3 anni70.80%
Variazione a 5 anni1.77%
Variazione dall'IPO-82.79%

Notizie e aggiornamenti recenti

Recent updates

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's Estimates

Aug 13
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's Estimates

Opiant awarded additional $2.1M from BARDA for its nasal opioid overdose treatment

Aug 08

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value Estimate

Aug 05
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value Estimate

Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue Forecasts

Mar 21
Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue Forecasts

Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good News

Nov 19
Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good News

These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably Well

Nov 17
These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably Well

Opiant Pharmaceuticals: Assessing Recent Insider Buying

Sep 19

Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings Forecasts

Aug 07
Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings Forecasts

Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)

Jun 09
Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)

The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New Forecasts

Mar 06
The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New Forecasts

News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts

Mar 05
News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts

Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.

Jan 27
Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.

Opiant Pharma secures additional BARDA grant of $3.5M for OPNT003

Dec 14

Opiant Pharmaceuticals receives $50M in convertible debt financing

Dec 10

Rendimenti per gli azionisti

OPNTUS PharmaceuticalsUS Mercato
7D-1.3%-3.7%0.5%
1Y-22.3%22.6%36.8%

Ritorno vs Industria: OPNT ha avuto una performance inferiore rispetto al US Pharmaceuticals che ha registrato un rendimento 22.6 % nell'ultimo anno.

Rendimento vs Mercato: OPNT ha avuto una performance inferiore al mercato US che ha registrato un rendimento 36.8 % nell'ultimo anno.

Volatilità dei prezzi

Is OPNT's price volatile compared to industry and market?
OPNT volatility
OPNT Average Weekly Movement1.5%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.1%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.0%

Prezzo delle azioni stabile: OPNT non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale di OPNT è diminuita da 19% a 1% nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
200538Roger Crystalwww.opiant.com

Opiant Pharmaceuticals, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Opiant Pharmaceuticals con la sua capitalizzazione di mercato?
OPNT statistiche fondamentali
Capitalizzazione di mercatoUS$108.80m
Guadagni(TTM)-US$33.09m
Ricavi(TTM)US$22.34m

4.9x

Rapporto P/S

-3.3x

Rapporto P/E

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
OPNT Conto economico (TTM)
RicaviUS$22.34m
Costo del fatturatoUS$29.45m
Profitto lordo-US$7.11m
Altre speseUS$25.97m
Guadagni-US$33.09m

Ultimi guadagni dichiarati

Sep 30, 2022

Prossima data di guadagno

n/a

Utile per azione (EPS)-6.28
Margine lordo-31.85%
Margine di profitto netto-148.12%
Rapporto debito/patrimonio netto67.1%

Come si è comportato OPNT nel lungo periodo?

Vedi performance storica e confronto